DBVT: DBV TECHNOLOGIES S.A. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | MPM BioImpact LLC | 6.20% | SEC | |
| 2026-08-06 | New 13G stake | RA Capital Management, L.P. | 5.80% | SEC |
Institutional ownership (Q2 2026)
78 institutions reported holding $336.93M of DBV TECHNOLOGIES S.A. on Form 13F (71 the quarter before). 17 opened a new position and 10 sold out. Shares held by institutions: +2%.
| Largest holders | Shares | Value |
|---|---|---|
| MPM BIOIMPACT LLC | 3,666,284 | $60.13M |
| Siren, L.L.C. | 1,857,362 | $30.46M |
| Vivo Capital, LLC | 1,844,758 | $30.25M |
| PERCEPTIVE ADVISORS LLC | 1,653,350 | $27.11M |
| BAKER BROS. ADVISORS LP | 1,461,425 | $23.97M |
| Artisan Partners Limited Partnership | 1,372,851 | $22.51M |
| UBS Group AG | 1,313,439 | $21.54M |
| MORGAN STANLEY | 954,908 | $15.66M |
| Logos Global Management LP | 915,000 | $15.01M |
| Patient Square Capital LP | 909,474 | $14.92M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.